In its most aggressive regional expansion initiative to date, World Courier has extended its network within China to 36 major cities, now offering cold chain transport services for biological specimens, investigational drugs and supplies to every clinical trial location currently approved by the Chinese State Food and Drug Administration.
With the establishment of World Courier's new domestic network in China, pharmaceutical companies can now be assured that all temperature-sensitive and clinical trial shipments are handled by trained personnel according to established SOPs and international IATA transportation standards. Only validated packaging complete with industry-accepted cold-pack mediums and temperature recording devices are used.
The expansion of World Courier will allow the temperature-controlled shipments to be handled directly between the following cities: Beijing, Changchun, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Hohhot, Jinan, Kunming, Lanzhou, Lhasa, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taiyun, Tianjin, Urumqi, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Zhengzhou and Zhuhai.
Mr Henning Voss, Director for World Courier, North Asia said, "China is poised to become the fourth largest pharmaceutical market by 2012. With our new operational network in place, we look forward to helping pharmaceutical companies, central labs and clinical research organizations improve their supply chain efficiencies in this vital, but complex country."
Mr. Voss further said, "China presents many infrastructure challenges for temperature-controlled and clinical trial shipments. In addition, domestic transport companies do not yet fully understand the many international standards at play in handling these types of shipments. As such, the real concerns and requirements of major pharmaceutical clients in China have not been adequately addressed until now."